ResearchAndMarkets.com recently issued a report on the global women’s health diagnostics market from 2022 to 2028.
The global women’s health diagnostics market is anticipated to grow at a substantial CAGR of 7.9% during the forecast period, according to the report.
“The major factor propelling the growth of the market includes the rapidly rising rate of obesity across the globe, especially among women. Women suffer from certain diseases and disorders mostly related to menstrual disorders, osteoporosis, obesity, ovarian cancer, breast cancer, pregnancy and childbirth, and mammography,” the report states.
The key factors that are contributing to the growth of the global women’s health diagnostics market include numerous government initiatives to promote women’s health awareness, increasing adoption of diagnostics imaging procedures and demand for point-of-care diagnostic testing, according to ResearchAndMarkets.com.
“However, the high cost of a dearth of skilled professionals and diagnostics tests acts as a restraint in the growth of the global women’s health diagnostics market,” the report adds.
Grand View Research recently issued a report on the global breast imaging market and predicts continued growth.
The global breast imaging market size was valued at $4.7 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030, according to Grand View Research.
“Factors such as the rising prevalence of breast cancer, technological breakthroughs in the domain of breast imaging, and investment from several organizations in breast cancer screening programs drive the market,” the report states. “According to the World Cancer Research Fund (WCRF) by 2030, the number of cases of breast cancer is likely to reach about 2.1 million globally. Also, as per the World Health Organization report on breast cancer released in March 2021, over 2.3 million women globally were diagnosed with the disease in 2020, with approximately 685,000 dying as a result of its severity. Breast imaging is the primary method of diagnosis for a vast majority of breast cancer patients globally. This aspect is expected to contribute to the growth of the market during the forecast period.”
The increased frequency of breast cancer in recent years along with its associated mortality at a young age, and its sometimes delayed presentation, has encouraged many women to find medical attention sooner rather than later in life.
However, Grand View Research points out that many breast cancer cases in developing countries are discovered at a late stage due to a lack of information about early warning symptoms and screening methods. As a result, numerous organizations all around the world are implementing breast cancer awareness initiatives and campaigns.
“These screening programs have been shown to save lives compared to unscreened populations,” Grand View Research shares. “Thus, rising screening programs and government initiatives are anticipated to upsurge the awareness associated with the diagnosis and treatment of breast cancer and thus might eventually aid the breast imaging market growth. Widespread research in the development of hybrid imaging systems provides high growth opportunities and also aids market growth. Recent developments in imaging technology have completely revolutionized the nature of treatment and the way it is approached. To view the metabolic data and anatomical characteristics of the organs, it has become more crucial to combine imaging methods like CT scans, MRIs, PET and others.”
